Cargando…
Haseman-Elston weighted by marker informativity
In the Haseman-Elston approach the squared phenotypic difference is regressed on the proportion of alleles shared identical by descent (IBD) to map a quantitative trait to a genetic marker. In applications the IBD distribution is estimated and usually cannot be determined uniquely owing to incomplet...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866733/ https://www.ncbi.nlm.nih.gov/pubmed/16451662 http://dx.doi.org/10.1186/1471-2156-6-S1-S50 |
_version_ | 1782133312899252224 |
---|---|
author | Franke, Daniel Kleensang, André Elston, Robert C Ziegler, Andreas |
author_facet | Franke, Daniel Kleensang, André Elston, Robert C Ziegler, Andreas |
author_sort | Franke, Daniel |
collection | PubMed |
description | In the Haseman-Elston approach the squared phenotypic difference is regressed on the proportion of alleles shared identical by descent (IBD) to map a quantitative trait to a genetic marker. In applications the IBD distribution is estimated and usually cannot be determined uniquely owing to incomplete marker information. At Genetic Analysis Workshop (GAW) 13, Jacobs et al. [BMC Genet 2003, 4(Suppl 1):S82] proposed to improve the power of the Haseman-Elston algorithm by weighting for information available from marker genotypes. The authors did not show, however, the validity of the employed asymptotic distribution. In this paper, we use the simulated data provided for GAW 14 and show that weighting Haseman-Elston by marker information results in increased type I error rates. Specifically, we demonstrate that the number of significant findings throughout the chromosome is significantly increased with weighting schemes. Furthermore, we show that the classical Haseman-Elston method keeps its nominal significance level when applied to the same data. We therefore recommend to use Haseman-Elston with marker informativity weights only in conjunction with empirical p-values. Whether this approach in fact yields an increase in power needs to be investigated further. |
format | Text |
id | pubmed-1866733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-18667332007-05-11 Haseman-Elston weighted by marker informativity Franke, Daniel Kleensang, André Elston, Robert C Ziegler, Andreas BMC Genet Proceedings In the Haseman-Elston approach the squared phenotypic difference is regressed on the proportion of alleles shared identical by descent (IBD) to map a quantitative trait to a genetic marker. In applications the IBD distribution is estimated and usually cannot be determined uniquely owing to incomplete marker information. At Genetic Analysis Workshop (GAW) 13, Jacobs et al. [BMC Genet 2003, 4(Suppl 1):S82] proposed to improve the power of the Haseman-Elston algorithm by weighting for information available from marker genotypes. The authors did not show, however, the validity of the employed asymptotic distribution. In this paper, we use the simulated data provided for GAW 14 and show that weighting Haseman-Elston by marker information results in increased type I error rates. Specifically, we demonstrate that the number of significant findings throughout the chromosome is significantly increased with weighting schemes. Furthermore, we show that the classical Haseman-Elston method keeps its nominal significance level when applied to the same data. We therefore recommend to use Haseman-Elston with marker informativity weights only in conjunction with empirical p-values. Whether this approach in fact yields an increase in power needs to be investigated further. BioMed Central 2005-12-30 /pmc/articles/PMC1866733/ /pubmed/16451662 http://dx.doi.org/10.1186/1471-2156-6-S1-S50 Text en Copyright © 2005 Franke et al; licensee BioMed Central Ltd http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Proceedings Franke, Daniel Kleensang, André Elston, Robert C Ziegler, Andreas Haseman-Elston weighted by marker informativity |
title | Haseman-Elston weighted by marker informativity |
title_full | Haseman-Elston weighted by marker informativity |
title_fullStr | Haseman-Elston weighted by marker informativity |
title_full_unstemmed | Haseman-Elston weighted by marker informativity |
title_short | Haseman-Elston weighted by marker informativity |
title_sort | haseman-elston weighted by marker informativity |
topic | Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866733/ https://www.ncbi.nlm.nih.gov/pubmed/16451662 http://dx.doi.org/10.1186/1471-2156-6-S1-S50 |
work_keys_str_mv | AT frankedaniel hasemanelstonweightedbymarkerinformativity AT kleensangandre hasemanelstonweightedbymarkerinformativity AT elstonrobertc hasemanelstonweightedbymarkerinformativity AT zieglerandreas hasemanelstonweightedbymarkerinformativity |